Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer

Table 2 Relationship between expression level of FKBP14 and clinical features in breast cancer

Variables	n	Low expression of FKBP14 (n = 40)	High expression of FKBP14 (n = 40)	χ2	P value
Age (yr)				0.056	0.813
≤ 60	53	27 (67.5)	26 (65)
> 60	27	13 (32.5)	14 (35)
Tumor size				10.769	0.002
≤ 2 cm	28	21 (52.5)	7 (17.5)
> 2 cm	52	19 (47.5)	33 (82.5)
Lymph node metastasis				25.208	< 0.001
No	48	35 (87.5)	13 (32.5)
Yes	32	5 (12.5)	27 (67.5)
Stage				11.250	0.001
I-II	64	38 (95)	26 (65)
III	16	2 (5)	14 (35)
Subtype				3.660	0.056
Triple negative	17	12 (30)	5 (12.5)
Non-triple negative	63	28 (70)	35 (87.5)